Literature DB >> 18025989

Aortic plaque imaging and monitoring atherosclerotic plaque interventions.

Yukihiko Momiyama1, Zahi A Fayad.   

Abstract

The atherosclerotic process that results in coronary artery disease (CAD) is recognized to be a generalized process that may involve the entire vasculature. The association between CAD and atherosclerotic plaques in the thoracic aorta has often been reported using transesophageal echocardiography. An autopsy study showed plaques in the abdominal aorta, but not in the thoracic aorta, to be severe in patients with cardiac events. However, studies evaluating an association between abdominal aortic plaques and CAD are scarce. Recently, magnetic resonance imaging (MRI) has become a useful tool for the noninvasive evaluation of atherosclerotic plaques in both the thoracic and abdominal aortas. Plaques in the thoracic and abdominal aortas were found to be characteristically associated with hypercholesterolemia and smoking, respectively, suggesting different susceptibilities to risk factors. Because patients have various risk factors, it seems to be preferable to evaluate atherosclerosis in multiple vascular beds than in just 1 bed. Magnetic resonance imaging can evaluate atherosclerosis in multiple vascular beds in the same examination session. Complex aortic plaques, especially in the abdominal aorta, were found to be associated with myocardial infarction and complex coronary lesions, suggesting a link between aortic and coronary plaque instability. Aortic MRI may thus be useful for identifying vulnerable patients. Moreover, MRI is a powerful tool to serially evaluate plaque progression and regression. Intensive lipid-lowering therapy can regress aortic plaques, but the susceptibility to lipid lowering and the process of plaque regression may differ between the thoracic and abdominal aortic plaques.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025989     DOI: 10.1097/rmr.0b013e31815a0e5d

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  9 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  [Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging].

Authors:  E Di Cesare; F Cademartiri; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; A Romagnoli; V Russo; F Sardanelli; L Natale; J Bogaert; A De Roos
Journal:  Radiol Med       Date:  2012-11-26       Impact factor: 3.469

Review 3.  Advanced techniques for MRI of atherosclerotic plaque.

Authors:  William S Kerwin; Gador Canton
Journal:  Top Magn Reson Imaging       Date:  2009-08

4.  Aortic atheroma as a source of stroke - assessment of embolization risk using 3D CMR in stroke patients and controls.

Authors:  Thomas Wehrum; Iulius Dragonu; Christoph Strecker; Florian Schuchardt; Anja Hennemuth; Johann Drexl; Thomas Reinhard; Daniel Böhringer; Werner Vach; Jürgen Hennig; Andreas Harloff
Journal:  J Cardiovasc Magn Reson       Date:  2017-09-06       Impact factor: 5.364

5.  The association between gallstone disease and plaque in the abdominopelvic arteries.

Authors:  Halil İbrahim Serin; Yunus Keser Yilmaz; Yaşar Turan; Ergin Arslan; Mustafa Fatih Erkoç; Aytaç Doğan; Mehmet Celikbilek
Journal:  J Res Med Sci       Date:  2017-01-27       Impact factor: 1.852

6.  Cardiovascular magnetic resonance parameters of atherosclerotic plaque burden improve discrimination of prior major adverse cardiovascular events.

Authors:  Venkatesh Mani; Paul Muntner; Samuel S Gidding; Silvia H Aguiar; Hamza El Aidi; Karen B Weinshelbaum; Hiroaki Taniguchi; Rob van der Geest; Johan H C Reiber; Sameer Bansilal; Michael Farkouh; Valentin Fuster; John E Postley; Mark Woodward; Zahi A Fayad
Journal:  J Cardiovasc Magn Reson       Date:  2009-04-24       Impact factor: 5.364

Review 7.  Cardiovascular magnetic resonance in carotid atherosclerotic disease.

Authors:  Li Dong; William S Kerwin; Marina S Ferguson; Rui Li; Jinnan Wang; Huijun Chen; Gador Canton; Thomas S Hatsukami; Chun Yuan
Journal:  J Cardiovasc Magn Reson       Date:  2009-12-15       Impact factor: 5.364

8.  Antibody phage display assisted identification of junction plakoglobin as a potential biomarker for atherosclerosis.

Authors:  Seraina Cooksley-Decasper; Hans Reiser; Daniela S Thommen; Barbara Biedermann; Michel Neidhart; Joanna Gawinecka; Gieri Cathomas; Fabian C Franzeck; Christophe Wyss; Roland Klingenberg; Paolo Nanni; Bernd Roschitzki; Christian Matter; Petra Wolint; Maximilian Y Emmert; Marc Husmann; Beatrice Amann-Vesti; Wilibald Maier; Steffen Gay; Thomas F Lüscher; Arnold von Eckardstein; Danielle Hof
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

9.  Aliskiren effect on plaque progression in established atherosclerosis using high resolution 3D MRI (ALPINE): a double-blind placebo-controlled trial.

Authors:  Georgeta Mihai; Juliet Varghese; Thomas Kampfrath; Liubov Gushchina; Lisa Hafer; Jeffrey Deiuliis; Andrei Maiseyeu; Orlando P Simonetti; Bo Lu; Sanjay Rajagopalan
Journal:  J Am Heart Assoc       Date:  2013-05-17       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.